Published in Chest on February 01, 1993
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
Sepsis biomarkers: a review. Crit Care (2010) 4.76
Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotechnol (2008) 4.40
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37
The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest (2010) 1.75
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 1.72
Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med (2009) 1.71
The host response to sepsis and developmental impact. Pediatrics (2010) 1.62
Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci (1997) 1.57
A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. Am J Respir Crit Care Med (2014) 1.53
Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am (2008) 1.47
Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury. Crit Care Med (2009) 1.47
Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care (2010) 1.47
Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patients. Resuscitation (2012) 1.47
Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed (2003) 1.30
Sepsis: Something old, something new, and a systems view. J Crit Care (2011) 1.29
Time course of cytokine levels in sepsis. Intensive Care Med (1995) 1.22
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
Scorpion venom and the inflammatory response. Mediators Inflamm (2010) 1.20
Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med (2010) 1.19
Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol (2003) 1.16
Are serum cytokines early predictors for the outcome of burn patients with inhalation injuries who do not survive? Crit Care (2008) 1.15
A mathematical simulation of the inflammatory response to anthrax infection. Shock (2008) 1.11
Identification of enhanced cytokine generation following sepsis. Dream of magic bullet for mortality prediction and therapeutic evaluation. Daru (2010) 1.09
Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis (2009) 1.09
Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled? Cardiovasc Res (2010) 1.08
Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis. Crit Care (2012) 1.08
Clinical sepsis and septic shock--definition, diagnosis and management principles. Langenbecks Arch Surg (2008) 1.08
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death. Expert Opin Investig Drugs (2011) 1.07
Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational study. PLoS One (2011) 1.05
Relationship between acid-base status and inflammation in the critically ill. Crit Care (2014) 1.02
Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care (2002) 1.01
The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study. Crit Care (2010) 1.01
The impact of obesity on sepsis mortality: a retrospective review. BMC Infect Dis (2013) 1.00
VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP. Thromb Haemost (2014) 0.99
Circulating inflammatory mediators in patients with fever: predicting bloodstream infection. Clin Diagn Lab Immunol (2001) 0.99
Neonatal sepsis and inflammatory mediators. Mediators Inflamm (2014) 0.98
Biomarkers of sepsis. Infect Chemother (2014) 0.95
Impact of sepsis on CD4 T cell immunity. J Leukoc Biol (2014) 0.94
Arginine and citrulline and the immune response in sepsis. Nutrients (2015) 0.93
Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.93
Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest (1998) 0.92
T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression. Crit Rev Immunol (2013) 0.91
A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J Surg Res (2013) 0.91
Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection. Ann Surg (1997) 0.91
A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis. Antimicrob Agents Chemother (2000) 0.90
Time course of endothelial damage in septic shock: prediction of outcome. Crit Care (2005) 0.89
Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain. Neuroscience (2008) 0.89
Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock. Crit Care (2011) 0.89
Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB. Mediators Inflamm (2010) 0.88
Endotoxin-induced arterial endothelial barrier dysfunction assessed by an in vitro model. Br J Pharmacol (1993) 0.88
Recombinant human Hsp70 protects against lipoteichoic acid-induced inflammation manifestations at the cellular and organismal levels. Cell Stress Chaperones (2011) 0.88
Association between lymphotoxin-alpha (tumor necrosis factor-beta) intron polymorphism and predisposition to severe sepsis is modified by gender and age. Crit Care Med (2010) 0.88
The bioartificial kidney: current status and future promise. Pediatr Nephrol (2013) 0.86
Cell-based approaches for the treatment of systemic inflammation. Nephrol Dial Transplant (2012) 0.86
Renal cell therapy and beyond. Semin Dial (2009) 0.86
Omega-3 fatty acids in critical illness. Nutr Rev (2010) 0.85
Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia. Intensive Care Med (2012) 0.85
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis (2014) 0.85
Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res (2005) 0.85
Microvascular changes explain the "two-hit" theory of multiple organ failure. Ann Surg (1998) 0.85
Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: preliminary data. Biomed Res Int (2013) 0.84
STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis. Clin Diagn Lab Immunol (2001) 0.83
Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection? Am J Reprod Immunol (2010) 0.83
The bioartificial kidney in the treatment of acute kidney injury. Curr Drug Targets (2009) 0.82
Acute respiratory distress syndrome in the septic surgical patient. World J Surg (2003) 0.81
CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol (2015) 0.81
TNF-alpha is a mediator of the anti-inflammatory response in a human neonatal model of the non-septic shock syndrome. Pediatr Surg Int (2006) 0.80
Prospectively validated predictions of shock and organ failure in individual septic surgical patients: the Systemic Mediator Associated Response Test. Crit Care (2000) 0.80
Plasma cytokine levels predict response to corticosteroids in septic shock. Intensive Care Med (2016) 0.79
Detection of cytoplasmic IL-1 beta in peripheral blood mononuclear cells from intensive care unit (ICU) patients. Clin Exp Immunol (1995) 0.79
Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity? Inflammation (2012) 0.78
'Preconditioning' with low dose lipopolysaccharide aggravates the organ injury / dysfunction caused by hemorrhagic shock in rats. PLoS One (2015) 0.78
Analysis of autofluorescence in polymorphonuclear neutrophils: a new tool for early infection diagnosis. PLoS One (2014) 0.77
IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol (2013) 0.77
The effects of hypertonic fluid administration on the gene expression of inflammatory mediators in circulating leucocytes in patients with septic shock: a preliminary study. Ann Intensive Care (2011) 0.77
Stem cells: the next therapeutic frontier. Trans Am Clin Climatol Assoc (2005) 0.77
Risk factors of organ failure in patients with bacteremic cholangitis. Dig Dis Sci (2012) 0.77
Significant in vivo anti-inflammatory activity of Pytren4Q-Mn a superoxide dismutase 2 (SOD2) mimetic scorpiand-like Mn (II) complex. PLoS One (2015) 0.77
Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases. Toxicol Sci (2015) 0.77
Utility of cytokine, adhesion molecule and acute phase proteins in early diagnosis of neonatal sepsis. J Nat Sci Biol Med (2017) 0.77
T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis. Clin Exp Immunol (2014) 0.76
IL-10 in antilipopolysaccharide immunity against systemic Klebsiella infections. Mediators Inflamm (2006) 0.76
Effects of ghrelin administration on the early postoperative inflammatory response after esophagectomy. Surg Today (2014) 0.76
Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care (2012) 0.76
Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity. Crit Rev Immunol (2016) 0.76
C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department. Crit Care (2009) 0.76
Evaluating the effects of protective ventilation on organ-specific cytokine production in porcine experimental postoperative sepsis. BMC Pulm Med (2015) 0.75
Thoracic epidural anesthesia decreases endotoxin-induced endothelial injury. BMC Anesthesiol (2014) 0.75
Calcium Contributes to the Cytotoxic Interaction Between Diclofenac and Cytokines. Toxicol Sci (2015) 0.75
Patient cytokine response in transfusion-associated sepsis. Infect Immun (1994) 0.75
Efficacy of intraoperative, single-bolus corticosteroid administration to prevent postoperative acute respiratory failure after oesophageal cancer surgery. Interact Cardiovasc Thorac Surg (2012) 0.75
Saikosaponin A protects against experimental sepsis via inhibition of NOD2-mediated NF-κB activation. Exp Ther Med (2015) 0.75
Ameliorative Effect of Vicenin-2 and Scolymoside on TGFBIp-Induced Septic Responses. Inflammation (2015) 0.75
Peripheral edema after esophagectomy. Surg Today (1998) 0.75
Qi-Shao-Shuang-Gan, a combination of Astragalus membranaceus saponins with Paeonia lactiflora glycosides, ameliorates polymicrobial sepsis induced by cecal ligation and puncture in mice. Inflammation (2011) 0.75
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA (2001) 10.03
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med (2000) 4.74
The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med (1999) 3.93
Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg (1996) 3.31
Has the mortality of septic shock changed with time. Crit Care Med (1998) 3.29
Erythropoietin response is blunted in critically ill patients. Intensive Care Med (1997) 3.20
Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med (1999) 2.93
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth (2001) 2.75
A profile of European intensive care unit physiotherapists. European Society of Intensive Care Medicine. Intensive Care Med (2000) 2.72
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med (2001) 2.56
Methylene blue administration in septic shock: a clinical trial. Crit Care Med (1995) 2.50
Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. Chest (2001) 2.43
The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit Care Med (2001) 2.34
Memantine induces reversible neurologic impairment in patients with MS. Neurology (2008) 2.34
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med (1999) 2.33
Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis (1999) 2.32
Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med (2008) 2.31
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation (1998) 2.26
Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest (1991) 2.25
Relation between oxygen consumption and oxygen delivery in patients after cardiac surgery. Anesth Analg (1993) 2.12
Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluation. Endoscopy (2001) 2.07
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest (1997) 2.07
Interleukin-10 production during septicaemia. Lancet (1994) 2.05
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
Relationship between oxygen uptake and oxygen delivery in septic patients: effects of prostacyclin versus dobutamine. Crit Care Med (1993) 2.00
Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med (1995) 1.97
Serial lactate determinations during circulatory shock. Crit Care Med (1983) 1.93
European participation in major intensive care journals. Intensive Care Med (1995) 1.93
European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy (2010) 1.89
Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg (2001) 1.87
Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. Clin Infect Dis (2008) 1.86
Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology (1993) 1.85
Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med (2000) 1.84
Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol (2005) 1.83
Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med (1998) 1.77
Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy (2009) 1.77
Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int (2002) 1.75
Expandable biliary metal stents for malignancies: endoscopic insertion and diathermic cleaning for tumor ingrowth. Gastrointest Endosc (1990) 1.73
Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology (2006) 1.72
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med (2000) 1.70
Continuous positive airway pressure as treatment for catathrenia (nocturnal groaning). Neurology (2006) 1.67
Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66
Driving with Parkinson's disease. A controlled laboratory investigation. Acta Neurol Scand (1992) 1.64
Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. J Med Genet (2006) 1.64
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg (1996) 1.63
The Brussels sedation scale: use of a simple clinical sedation scale can avoid excessive sedation in patients undergoing mechanical ventilation in the intensive care unit. Br J Anaesth (1999) 1.63
Hemodynamic responses to successful weaning from mechanical ventilation after cardiovascular surgery. Intensive Care Med (2000) 1.62
Estimating left ventricular filling pressure during positive end-expiratory pressure in humans. Am Rev Respir Dis (1991) 1.61
Terahertz quantum cascade lasers operating up to ∼ 200 K with optimized oscillator strength and improved injection tunneling. Opt Express (2012) 1.59
Effects of propofol on human microcirculation. Br J Anaesth (2008) 1.56
Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med (1995) 1.53
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53
Do established prognostic factors explain the different mortality rates in ICU septic patients around the world? Minerva Anestesiol (2012) 1.53
Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol (1997) 1.51
Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation (1989) 1.50
High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol (1989) 1.50
Sepsis, severe sepsis or sepsis syndrome: need for clarification. Intensive Care Med (1992) 1.48
Coagulopathy induced by hydroxyethyl starch. Anesth Analg (1997) 1.47
Roundtable Conference on Clinical Trials for the Treatment of Sepsis. Brussels, March 12-14, 1994. Chest (1995) 1.47
Isodisomy of chromosome 6 in a newborn with methylmalonic acidemia and agenesis of pancreatic beta cells causing diabetes mellitus. J Clin Invest (1994) 1.46
Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant (2000) 1.46
Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology (1995) 1.44
IL-6 and TNF alpha in ascitic fluid during spontaneous bacterial peritonitis. Dig Dis Sci (1991) 1.44
Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock. Anesth Analg (1989) 1.44
Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand (1994) 1.44
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain (2006) 1.43
Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg (1992) 1.42
Doctors' perceptions of the effects of interventions tested in prospective, randomised, controlled, clinical trials: results of a survey of ICU physicians. Intensive Care Med (2001) 1.41
Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med (1992) 1.40
Atropine administration in experimental electromechanical dissociation. Am J Emerg Med (1992) 1.39
Thermodilution for measurement of cardiac output during artificial ventilation. Intensive Care Med (1988) 1.39
Bretylium tosylate versus lidocaine in experimental cardiac arrest. Am J Emerg Med (1990) 1.39
Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure. Chest (1989) 1.38
Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm. Ann Thorac Surg (1996) 1.37
Treatment of benign essential tremor with propranolol. A controlled clinical trial. Acta Neurol Scand (1973) 1.37
Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res (1998) 1.34
Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology (1992) 1.32
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur J Clin Microbiol Infect Dis (2006) 1.29
Effects of nitric oxide in septic shock. Am J Respir Crit Care Med (2000) 1.27
Veno-arterial carbon dioxide gradient in human septic shock. Chest (1992) 1.26
Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech (2001) 1.25
Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J (1997) 1.25
Lactate production by the lungs in acute lung injury. Am J Respir Crit Care Med (1997) 1.25
Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model. Surg Endosc (2001) 1.19
Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol (1999) 1.19
Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 1.14
Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res (1999) 1.14
A profile of European ICU nursing. Intensive Care Med (1998) 1.13